// App-Quantinova.ai

: Who should not undergo alpps for colorectal liver metastases?

Researchers

Presenter

  • P. Olthof

Principal Investigators

  • J. Huiskens

  • E. Schadde

  • H. Lang

  • M. Malago

  • H. Petrowsky

  • E. de Santibanes

  • K. Oldhafer

  • T. van Gulik

Medical Centers

  • Department of Medical Oncology, VU University Medical Center, Amsterdam, Netherlands

  • Department of Surgery, Reinier de Graaf Gasthuis, The Netherlands

  • Academic Medical Center, Amsterdam, Netherlands

  • Rush University Medical Center, United States

  • Cantonal Hospital Winterthur, Winterthur, Switzerland

  • Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland

  • Universitatsmedizin, Mainz, Germany

  • University College London, Royal Free Hospitals, United Kingdom

  • Balgrist University Hospital, Zurich, Switzerland

  • Hospital Durand, Buenos Aires, Argentina

  • Asklepios Hospital Barmbek, Germany

Locations

  • Netherlands

  • United States

  • Switzerland

  • Germany

  • United Kingdom

  • Argentina

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • Colorectal liver metastases

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A